Full-Time

Specialist

Mechanical Coordinator

Confirmed live in the last 24 hours

Merck

Merck

10,001+ employees

Develops medicines and vaccines for health issues

Compensation Overview

$85.6k - $134.8k/yr

Mid, Senior

No H1B Sponsorship

Linden, NJ, USA

Hybrid work model consisting of three total days on-site per week, Monday - Thursday, with Friday designated as a remote-working day.

Category
Mechanical Maintenance and Reliability Engineering
Mechanical Engineering
Requirements
  • A strong mechanical aptitude
  • Maintenance experience in manufacturing environments
  • History interacting with skilled trades (Piping, Electrical, Millwrights, Instrumentation, 3rd party contractors and vendors)
  • Ability to read and understand P&IDs and technical/mechanical diagrams
  • Familiarity with Change Management processes and principles
  • Excellent organizational skills with an ability to multi-task
  • Effective interpersonal and communication skills, both verbal and written
  • A collaborative mindset
  • Desire and willingness to learn, contribute and lead
  • Track-record of independent problem-solving
  • Fluent in Microsoft Office, use of email.
Responsibilities
  • Serve as a team member supporting the Modality Agnostic Chemistry Scaleup (MACS) Center
  • Contribute to equipment and facility design, system commissioning/qualification, and operational readiness planning
  • Lead the daily mechanical activities and be responsible for the planning and execution supervision of maintenance, improvement and yearly shutdown/turnaround efforts
  • Learn, understand, and apply the maintenance requirements and safe work practices
  • Prioritize mechanical work to meet the timelines of the business
  • Implement and develop Lockout/Tagout and Energy Control Procedures
  • Perform Emergency Repairs/Troubleshooting
  • Conduct Calibration/Routine Preventative Maintenance
  • Set up and re-qualify Process Equipment
  • Design small facility modifications
  • Source and procure materials
  • Interact with Computerized Maintenance Management System (CMMS) applications
Desired Qualifications
  • Maintenance experience in GMP pilot plants or manufacturing environments
  • Familiarity with US and EU Safety and GMP compliance regulations
  • Experience with Potent Compound processing and containment systems (e.g., isolators), or clean room facilities
  • Experience operating/maintaining pilot scale or prep lab scale equipment
  • Experience with coordinating maintenance activities around processing activities to support reliable facility operation
  • Experience with GMP facility design, equipment start-up and/or qualification
  • Experience with high-risk work including, but not limited to, Lockout/Tagout, Hazardous Energy Control, Elevated Work, and Confined Space Entry
  • Experience with Electrical Classifications for solvent and dust (Class I and II, Div I and II)
  • Experience with preparing Standard Operating Procedures (SOP) and cGMP documents
  • Trained in use of SAP for Plant Maintenance management
  • Experience working in an environment with an Automation System (DeltaV, PLC, etc.)

Merck develops medicines and vaccines to address significant health challenges such as cardiovascular disease, diabetes, and cancer. The company conducts extensive research and development to create new treatments, focusing on the pharmaceutical and biotechnology sectors. Merck generates revenue through the sale of prescription medications, vaccines, and animal health products. A key aspect of Merck's approach is its commitment to patient assistance programs, which provide free medicines and vaccines to eligible patients. Additionally, Merck supports healthcare professionals with resources like Merck Connect and Merck Manuals, distinguishing itself from competitors by its comprehensive support for both patients and healthcare providers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Kenilworth, Illinois

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • Merck invests $1 billion in a new vaccine manufacturing site in North Carolina.
  • Merck's collaboration with Cyprumed aims to make peptide drugs orally available.
  • Merck recognized as a 'Digital Health Innovation Leader' for two consecutive years.

What critics are saying

  • Halozyme's lawsuit over Keytruda formulation could impact Merck's product pipeline.
  • Tariffs add $200 million in costs, affecting Merck's financial performance.
  • Novartis' $23 billion US expansion may impact Merck's oncology market share.

What makes Merck unique

  • Merck's R&D focuses on innovative medicines for cardiovascular, diabetes, and cancer.
  • Merck offers patient assistance programs providing free medicines to qualified patients.
  • Merck integrates medical resources into Microsoft Copilot Studio, enhancing clinical workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Holidays

Paid Vacation

Paid Sick Leave

Hybrid Work Options

Flexible Work Hours

Company News

Investing.com
Apr 24th, 2025
Halozyme Sues Merck Over Subcutaneous Keytruda Formulation, Seeks Injunctive Relief

Stocktwits - Biopharmaceutical company Halozyme Therapeutics, Inc. (NASDAQ:HALO) filed a patent infringement lawsuit against Merck (NSE:PROR) & Co., Inc. (MRK) on Thursday, alleging that the latter uses Halozyme's patented MDASE technology to develop subcutaneous (SC) Keytruda.

ROI-NJ
Apr 24th, 2025
Merck Shares Fall After Company Lowers Outlook On Tariff Impact

Shares of drug maker Merck & Co. declined Thursday after the company lowered its full-year profit guidance and said tariffs would add on $200 million in costs this year. Sales of its blockbuster cancer drug Keytruda failed to beat expectations and sales of the vaccine Gardasil declined in the quarter.The stock dropped 1.24% to $77.76 as of 10:27 a.m. after rising in premarket trading before the report.The drugmaker lowered its adjusted earnings per share outlook for 2025 to between $8.82 and $8.97 from a range of between $8.88 and $9.03 per share previously. Merck said the adjusted outlook accounts for the impact of current tariffs, which it said will cost $200 million.Merck adjusted earnings per share were $2.22 and beat expectations. For the first quarter, Merck said net income increased 6.7% from the same period a year ago to $5.08 billion from $4.76 million

SDBN
Apr 24th, 2025
Halozyme Sues Merck for Patent Infringement over Subcutaneous Keytruda Formulation

Halozyme sues Merck for patent infringement over subcutaneous Keytruda formulation.

Healthcare Dive
Apr 16th, 2025
Merck Manuals Integrates Medical Reference Within Microsoft Copilot Studio

This collaboration exemplifies a commitment to enhancing clinical workflows by incorporating Merck Manuals' authoritative content into Microsoft's healthcare agent service in Copilot Studio.

Sandra Gona
Apr 16th, 2025
India logs 2,430 new Covid cases_Spider information

As a result of these efforts, Merck has been recognized as a "Digital Health Innovation Leader" for two consecutive years since 2023.